Sadot Group Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $SDOT in the last 30 days.
See all $SDOT insider activity →Sadot Group Inc. (SDOT) rose 10.3% in pre-market trading after filing a registration for a secondary offering of up to 4.25 million shares. The surge follows debt restructuring and AI-driven transformation, with a tight float amplifying volatility. The CFO's resignation and Nasdaq compliance status were also noted.
Sadot Group Inc. (SDOT) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. Item 1.02 Termination of a Material Definitive Agreement. To the extent required by Item 1.02, the information contained in Item 5.02 of this Current Report on Form 8-K is incorporated herein by reference. Item 5.02 Departure of Directors or Certain Officers; Election of Director
Picard Medical (PMI) rose 40% after reporting Q2 revenue growth of 39% to $3.0M. Sadot Group (SDOT) surged 100% despite zero revenue, with net income up to $35.2M. Capricor Therapeutics (CAPR) gained 11% after FDA extended review for deramiocel. GRI Bio (GRI) climbed 10% with Phase 2a data selected for ERS 2026. Biomea Fusion (BMEA) rose 14% after completing Phase 2 diabetes trial enrollment. Yarrow Bioscience (YARW) advanced 12% with Graves' disease trial updates.
Over the past 7 days, alphai's AI scored 8 news stories mentioning SDOT (Sadot Group Inc.). Coverage has skewed bullish: 6 bullish, 2 neutral, and 0 bearish.
Recent SDOT coverage spans corporate actions, market movers and earnings.
The secondary offering registration and recent debt‑for‑equity cleanup provide fresh capital and reduce float, likely supporting short‑term upside.
Executive turnover may cause short‑term volatility and affect confidence in financial reporting.
Unusual earnings profile with net income jump despite zero revenue.
High volatility due to low float and recent positive restructuring news may drive further short-term price swings.
Significant price rise without a disclosed catalyst.
alphai scores every news story that mentions SDOT with an AI model for sentiment and relevance, and aggregates insider trades from Sadot Group Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Sadot Group Inc. (SDOT) rose 10.3% in pre-market trading after filing a registration for a secondary offering of up to 4.25 million shares. The surge follows debt restructuring and AI-driven transformation, with a tight float amplifying volatility. The CFO's resignation and Nasdaq compliance status were also noted.
2 min readSadot Group Inc. (SDOT) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. Item 1.02 Termination of a Material Definitive Agreement. To the extent required by Item 1.02, the information contained in Item 5.02 of this Current Report on Form 8-K is incorporated herein by reference. Item 5.02 Departure of Directors or Certain Officers; Election of Director
2 min readPicard Medical (PMI) rose 40% after reporting Q2 revenue growth of 39% to $3.0M. Sadot Group (SDOT) surged 100% despite zero revenue, with net income up to $35.2M. Capricor Therapeutics (CAPR) gained 11% after FDA extended review for deramiocel. GRI Bio (GRI) climbed 10% with Phase 2a data selected for ERS 2026. Biomea Fusion (BMEA) rose 14% after completing Phase 2 diabetes trial enrollment. Yarrow Bioscience (YARW) advanced 12% with Graves' disease trial updates.
3 min readSadot Group Inc. shares surged 90% to $24.98 on Monday, driven by debt restructuring and early revenue from its AI-powered trading platform, TradeOS. The company reported $1M in preliminary gross revenue from TradeOS in July, while focusing on balance-sheet improvements and Nasdaq compliance. The stock's volatility is amplified by a low float following a reverse split.
2 min readU.S. stocks were mixed Monday, with the Nasdaq Composite down 150 points. The Chicago Fed National Activity Index fell to -0.08 in July, suggesting economic slowdown. Expion360 (XPON) surged 133% after a $3.425M acquisition and a $9M share offering. CID HoldCo (DAIC) and Sadot Group (SDOT) also rose, while FLZH, RFAI, and KNRX declined.
2 min readSadot Group Inc. (SDOT) stock surged 39.4% in pre-market trading to $18.37, driven by debt restructuring, AI technology integration, and a reduced float. The company reported $1M in preliminary revenue from its new TradeOS platform. The rally is company-specific, with broader markets showing no significant impact.
1 min readSadot Group Inc. (SDOT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Background As previously disclosed, on February 9, 2026, Sadot Group Inc. (the “Company”) issued four 8% Unsecured OID Debentures each in the original principal amount of $271,739.13, in the aggregate original principal amount
1 min readSadot Group Inc. (SDOT) surged 67% to $14.095 on Friday after resetting a $4M convertible note's conversion price to $8. Volume reached 14.44M shares. A September vote may unlock $200M in financing. The company's cash position is weak, with negative shareholders' equity and high liabilities. Q2 net income was $40.08M, driven by a deconsolidation gain.
2 min readSadot Group Inc. (SDOT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Background As previously disclosed, on February 9, 2026, Sadot Group Inc. (the “Company”) issued four 8% Unsecured OID Debentures each in the original principal amount of $271,739.13, in the aggregate original principal amount
2 min readSadot Group Inc. (SDOT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Background As previously disclosed, on February 9, 2026, Sadot Group Inc. (the “Company”) issued four 8% Unsecured OID Debentures each in the original principal amount of $271,739.13, in the aggregate original principal amount
4 min read
